Councils to Accelerate Research Excellence (CARE Councils)


World-class support for areas of significant therapeutic need

Velocity’s CARE Councils are expert-led groups that address specific intersections of therapeutic areas, diseases, specialty populations, and other factors that pose challenges to efficient clinical development.

Each Velocity CARE Council comprises experienced physicians, veteran clinicians, and operational experts. These centralized councils meet to discuss scientific trends, review high-priority clinical trials, and refine best practices for Velocity sites worldwide.

CARE Councils enhance the way all Velocity sites support specialty research programs, and ensure patients are engaged with an authentic, informed touch.

Portrait Of Smiling Female Doctor Wearing White Coat With Stethoscope Sitting Behind Desk In Office

Renowned investigators and experienced sites


Unparalleled patient access and engagement

U.S. Department of Health and Human Services (HHS) Officials Meet With Leaders to Discuss COVID-19 Vaccine Clinical Trials and Patient Recruitment

Operational and quality experts

CARE Council Logo_Horizontal White

A transformative model to confront the inefficiencies that plague clinical trials

1: Drug Development Technology. (2012). Clinical trial delays: America’s patient recruitment dilemma. | 2: Tufts Center for the Study of Drug Development. (2013). Impact report: 89% of trials meet enrollment, but timelines slip, half of sites under-enroll. Vol. 15, No. 1. | 3: Kaitin, K. I. (2006). Fastest drug developers consistently best peers on key performance metrics. Tufts Center for the Study of Drug Development Impact Report, 8(5). | 4: Hess, J. (n.d.). Web-based patient recruitment: best opportunity to accelerate clinical trials.

of U.S. trials fail to meet enrollment timelines
of sites miss enrollment targets
daily operational losses for Sponsors for delayed trials
potential daily opportunity cost losses for delayed trials

Meet Velocity's CARE Council leaders

CARE Councils deliver a convergence of industry-leading expertise, global reach, and proven sites

In-house monitoring, quality assurance, and audit support

Integrated operations to expedite site selection and startup

World-class recruitment teams and AI-enabled technologies

Therapeutic and Specialty Population Expertise

Experienced Investigators, Specialists, and Research Staff

Therapeutic expertise

Specialty populations

Specialized trial support

  • Biosimilars
  • Combination products
  • Devices
  • Decentralized
  • Diagnostics
  • Hospital
  • Interventional
  • Observational
  • Overnight

Let's talk about your next trial